The effects of adding NovoMix 30 to other antidiabetic medicines taken by mouth (metformin, sulphonylureas and pioglitazone) have also been studied in four studies involving a total of 905 patients.
NovoMix 30 toimet lisamisel teistele suukaudsetele diabeediravimitele (metformiin, sulfonüüluuread ja pioglitasoon) uuriti neljas uuringus, milles osales kokku 905 patsienti.